Orchard Therapeutics
ORTX
$16.70
Share price
0.00%
Change (1 day)
244.33%
Change (1 year)
Operating Margin for Orchard Therapeutics (ORTX)
Operating Margin as of April 2024 (TTM): -129.00%
According to Orchard Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -129.00%. At the end of 2021 the company had an Operating Margin of -8,582.45%.
Operating Margin history for Orchard Therapeutics from 2019 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -8,582.45% | 45.84% |
| 2020 | -5,884.78% | -10.73% |
| 2019 | -6,592.20% | -40.38% |
| 2018 | -11,056.12% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -591.52% | 358.54% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -129.00% | 0.00% | 🇬🇧 UK |
 Novavax NVAX | -149.57% | 15.95% | 🇺🇸 USA |
 Novocure
NVCR | -37.52% | -70.91% | Jersey |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.